-
1
-
-
0035668874
-
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
-
Mismetti P, Laporte S, Darmon JY, et al.: Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001, 88:913-930.
-
(2001)
Br J Surg
, vol.88
, pp. 913-930
-
-
Mismetti, P.1
Laporte, S.2
Darmon, J.Y.3
-
2
-
-
0037111563
-
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
-
Prandoni P, Lensing AW, Piccioli A, et al.: Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002, 100:3484-3488. This is the largest prospective cohort series reporting the incidence of recurrent thrombosis and bleeding in patients with and without cancer.
-
(2002)
Blood
, vol.100
, pp. 3484-3488
-
-
Prandoni, P.1
Lensing, A.W.2
Piccioli, A.3
-
3
-
-
0030751133
-
Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment
-
ENOXACAN Study Group
-
Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group. Br J Surg 1997, 84:1099-1103.
-
(1997)
Br J Surg
, vol.84
, pp. 1099-1103
-
-
-
4
-
-
0037187892
-
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer
-
Bergqvist D, Agnelli G, Cohen AT, et al.: Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002, 346:975-980. This is the first randomized, controlled trial to examine the efficacy and safety of extending prophylaxis beyond hospitalization in patients undergoing surgery for cancer.
-
(2002)
N Engl J Med
, vol.346
, pp. 975-980
-
-
Bergqvist, D.1
Agnelli, G.2
Cohen, A.T.3
-
5
-
-
0041635601
-
Prolonged prophylaxis against venous thromboembolism with enoxaparin in patients undergoing surgery for malignancy: 1-Year survival study
-
Bergqvist D, Agnelli G, Cohen A, et al.: Prolonged prophylaxis against venous thromboembolism with enoxaparin in patients undergoing surgery for malignancy: 1-year survival study. Blood 2002, 100:502a.
-
(2002)
Blood
, vol.100
-
-
Bergqvist, D.1
Agnelli, G.2
Cohen, A.3
-
6
-
-
0036622940
-
Preventing thromboembolic complications in cancer patients after surgery: A role for prolonged thromboprophylaxis
-
Rasmussen MS: Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev 2002, 28:141-144.
-
(2002)
Cancer Treat Rev
, vol.28
, pp. 141-144
-
-
Rasmussen, M.S.1
-
7
-
-
0035822248
-
Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: A meta-analysis of the randomised trials
-
Eikelboom JW, Quinlan DJ, Douketis JD: Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001, 358:9-15.
-
(2001)
Lancet
, vol.358
, pp. 9-15
-
-
Eikelboom, J.W.1
Quinlan, D.J.2
Douketis, J.D.3
-
8
-
-
0035923406
-
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: A systematic review
-
Hull RD, Pineo GF, Stein PD, et al.: Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 2001, 135:858-869.
-
(2001)
Ann Intern Med
, vol.135
, pp. 858-869
-
-
Hull, R.D.1
Pineo, G.F.2
Stein, P.D.3
-
9
-
-
0034255417
-
The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence-based review
-
Marras LC, Geerts WH, Perry JR: The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 2000, 89:640-646.
-
(2000)
Cancer
, vol.89
, pp. 640-646
-
-
Marras, L.C.1
Geerts, W.H.2
Perry, J.R.3
-
10
-
-
0008592537
-
The continuing risk of venous thromboembolism following operation for glioma: Findings from the Glioma Outcomes Project
-
Anderson F, Huang W, Sullivan C, et al.: The continuing risk of venous thromboembolism following operation for glioma: findings from the Glioma Outcomes Project. Thromb Haemost 2001, 86(suppl):OC902.
-
(2001)
Thromb Haemost
, vol.86
, Issue.SUPPL.
-
-
Anderson, F.1
Huang, W.2
Sullivan, C.3
-
11
-
-
0034726370
-
Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: A meta-analysis
-
Iorio A, Agnelli G: Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med 2000, 160:2327-2332.
-
(2000)
Arch Intern Med
, vol.160
, pp. 2327-2332
-
-
Iorio, A.1
Agnelli, G.2
-
12
-
-
0036924295
-
Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis
-
Goldhaber SZ, Dunn K, Gerhard-Herman M, et al.: Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 2002, 122:1933-1937.
-
(2002)
Chest
, vol.122
, pp. 1933-1937
-
-
Goldhaber, S.Z.1
Dunn, K.2
Gerhard-Herman, M.3
-
13
-
-
0021042689
-
Incidence of post-operative deep vein thrombosis in gynaecological oncology
-
Crandon AJ, Koutts J: Incidence of post-operative deep vein thrombosis in gynaecological oncology. Aust N Z J Obstet Gynaecol 1983, 23:216-219.
-
(1983)
Aust N Z J Obstet Gynaecol
, vol.23
, pp. 216-219
-
-
Crandon, A.J.1
Koutts, J.2
-
14
-
-
0035690935
-
Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: A randomized trial
-
Maxwell GL, Synan I, Dodge R, et al.: Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial. Obstet Gynecol 2001, 98:989-995.
-
(2001)
Obstet Gynecol
, vol.98
, pp. 989-995
-
-
Maxwell, G.L.1
Synan, I.2
Dodge, R.3
-
15
-
-
0037067889
-
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: A randomized controlled study
-
Meyer G, Marjanovic Z, Valcke J, et al.: Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med 2002, 162:1729-1735. This is the first published, randomized trial to compare the efficacy and safety of LMWH with warfarin for the prevention of recurrent venous thrombosis in cancer patients.
-
(2002)
Arch Intern Med
, vol.162
, pp. 1729-1735
-
-
Meyer, G.1
Marjanovic, Z.2
Valcke, J.3
-
16
-
-
0037775584
-
Low-molecular-weight heparin versus coumarin for the prevention of recurrent venous thromboembolism in cancer
-
in press
-
Lee AYY, Levine MN, Baker RI, et al.: Low-molecular-weight heparin versus coumarin for the prevention of recurrent venous thromboembolism in cancer. New Engl J Med 2003, in press. This is the first publication to show superiority of low-molecular-weight heparin dalteparin over oral anticoagulant therapy for secondary prophylaxis in cancer patients with venous thromboembolism.
-
(2003)
New Engl J Med
-
-
Lee, A.Y.Y.1
Levine, M.N.2
Baker, R.I.3
-
17
-
-
0037721211
-
A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by warfarin sodium
-
Hull RD, Pineo GF, Mah AF, et al.: A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by warfarin sodium. Blood 2002, 100:148a.
-
(2002)
Blood
, vol.100
-
-
Hull, R.D.1
Pineo, G.F.2
Mah, A.F.3
-
18
-
-
6844254566
-
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis
-
Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group
-
Decousus H, Leizorovicz A, Parent F, et al.: A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998, 338:409-415.
-
(1998)
N Engl J Med
, vol.338
, pp. 409-415
-
-
Decousus, H.1
Leizorovicz, A.2
Parent, F.3
-
19
-
-
0034833886
-
Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy
-
Luk C, Wells PS, Anderson D, et al.: Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy. Am J Med 2001, 111:270-273.
-
(2001)
Am J Med
, vol.111
, pp. 270-273
-
-
Luk, C.1
Wells, P.S.2
Anderson, D.3
-
20
-
-
0038427887
-
Low molecular weight heparin therapy and survival in advanced cancer
-
Kakkar AK, Kadziola Z, Williamson RC, et al.: Low molecular weight heparin therapy and survival in advanced cancer. Blood 2002, 100:148a.
-
(2002)
Blood
, vol.100
-
-
Kakkar, A.K.1
Kadziola, Z.2
Williamson, R.C.3
|